ORIGINAL ARTICLE
Immunoreactive hepatic stellate cells in biopsy material in children with chronic hepatitis B. The first report in pediatric patients
 
More details
Hide details
 
Submission date: 2015-03-05
 
 
Final revision date: 2015-04-10
 
 
Acceptance date: 2015-05-03
 
 
Publication date: 2015-10-23
 
 
Pol J Pathol 2015;66(3):224-230
 
KEYWORDS
TOPICS
ABSTRACT
The research objective was to identify and quantify the immunohistochemically (IHC) stained hepatic stellate cells (HSCs) in children with chronic hepatitis B (CHB), including staging (S), location in the hepatic lobule, and correlation with hepatocyte count.
Retrospective morphological analysis was based on liver biopsies obtained from 70 CHB children before antiviral treatment. To determine fibrosis stage, the Batts and Ludwig scoring system was applied. Immunohistochemical examinations used monoclonal antibodies against -SMA.
IHC observations in CHB children revealed a significant positive correlation between the mean number of -SMA immunopositive HSCs within the hepatic lobule (r = 0.518; p < 0.001) and fibrosis stage. In biopsy specimens with intensive fibrosis, most HSCs had an elongated shape and demonstrated evidently strong immunoexpression of cytoskeletal protein -SMA. The mean counts of HSCs/100 hepatocytes (in high power field) in 4 study groups, i.e. with S-0, S-1, S-2, S-3, were 5.00; 5.98; 9.80; 12.19, respectively. Interestingly, in most groups the highest count of immunoreactive HSCs/100 hepatocytes was in the intermediate zone, indicating its high metabolic activity in liver fibrogenesis.
Immunohistochemical and statistical investigations of HSCs in children with CHB showed a close positive correlation of cell count with fibrosis intensity, which may have prognostic implications in this pathology.
REFERENCES (42)
1.
Lee Y, Friedman SL. Fibrosis in the liver: acute protection and chronic disease. Prog Mol Biol Transl Sci 2010; 97: 151-200.
 
2.
Maia JM, Maranhão Hde S, Sena LV, et al. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission. Eur J Gastroenterol Hepatol 2010; 22: 264-269.
 
3.
Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol 2014; 20: 2515-2532.
 
4.
Popov J, Schuppan D. Targeting liver fibrosis: strategies for development of validation of anti fibrotic therapies. Hepatology 2009; 50: 1294-1306.
 
5.
Tacke F, Weiskirchen R. Liver fibrosis – pathogenesis and novel therapeutic approaches. Internist (Berl) 2010; 51: 21-29.
 
6.
Sobaniec-Lotowska ME, Lotowska JM, Lebensztejn DM. Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study. World J Gastroenterol 2007; 13: 2918-2922.
 
7.
Zhou K, Lu LG. Assessment of fibrosis in chronic liver diseases. J Dig Dis 2009; 10: 7-14.
 
8.
Stepień M, Czarkowski MP. Hepatitis B in Poland in 2011. Przegl Epidemiol 2013; 67: 239-245.
 
9.
Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
 
10.
Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011; 25: 195-206.
 
11.
Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-178.
 
12.
Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010; 7: 425-436.
 
13.
Hernández-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6: 425-456.
 
14.
Mallat A, Lotersztajn S. Reversion of hepatic stellate cell to a quiescent phenotype: From myth to reality? J Hepatol 2013; 59: 383-386.
 
15.
Nagatsuma K, Hano H, Murakami K, et al. Hepatic stellate cells that coexpress LRAT and CRBP-1 partially contribute to portal fibrogenesis in patients with human viral hepatitis. Liver Int 2014; 34: 243-252.
 
16.
Nepomnyashchikh GI, Aidagulova SV, Nepomnyashchikh DL, et al. Ultrastructural and immunohistochemical study of hepatic stellate cells over the course of infectious viral fibrosis and cirrhosis of the liver. Bull Exp Biol Med 2006; 142: 723-728.
 
17.
Elpek GÖ. Cellular and molecular mechanisms in pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20: 7260-7672.
 
18.
Wang Y, Li J, Wang X, Sang M, et al. Hepatic stellate cells, liver innate immunity, and hepatitis C virus. J Gastroenterol Hepatol 2013; 28 Suppl. 1: 112-115.
 
19.
Lebensztejn DM, Kaczmarski M, Sobaniec-Lotowska ME, et al. Blind liver biopsy in children – diagnostic significance and complications in authors’ own material. Med Sci Monit 2000; 6: 1155-1158.
 
20.
Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: Usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol 2003; 98: 1664-1665.
 
21.
Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Electron microscopic alterations in intermediate hepatocyte-like cells in children with chronic hepatitis B. The first report in pediatric patients. Eur J Gastroenterol Hepatol 2010; 22: 741-747.
 
22.
Sobaniec-Lotowska ME, Lebensztejn DM, Lotowska JM, et al. Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis. Adv Med Sci 2011; 56: 172-179.
 
23.
Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis – ultrastructural findings. The first report in pediatric patients. Scand J Gastroenterol 2013; 48: 352-357.
 
24.
Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
 
25.
Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem 2004; 50: 1299-1300.
 
26.
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174.
 
27.
Arends JE, de Knegt RJ, Van Erpecum KJ, et al. Diagnosis of hepatic fibrosis and cirrhosis. Ned Tijdschr Geneeskd 2007; 151: 1502-1506.
 
28.
Ionescu AG, Streba LA, Vere CC, et al. Histopathological and immunohistochemical study of hepatic stellate cells in patients with viral C chronic liver disease. Rom J Morphol Embryol 2013; 54: 983-991.
 
29.
Lebensztejn DM, Skiba E, Kaczmarski M, et al. Serum cystatin C concentration does not predict advanced liver disease in children with chronic hepatitis B. Clinica Chim Acta 2004; 347: 227-228.
 
30.
Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, et al. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12: 3338-3343.
 
31.
Lebensztejn DM, Skiba E, Sobaniec-Lotowska ME, et al. Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term lamivudine treatment. Hepatogastroenterology 2007; 54: 834-838.
 
32.
Castera L. Hepatitis B: are non-invasive markers of liver fibrosis reliable? Liver Int 2014; 34 Suppl 1: 91-96.
 
33.
Lotowska JM, Lebensztejn DM. -SMA immunoreactive hepatic stellate cells (HSCs) in the course of chronic hepatitis B. The first report in pediatric patients. 19th Congress of Polish Society of Pathologists. Pol J Pathology 2013; 64 (Suppl. 1): 103.
 
34.
Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027-1033.
 
35.
Guido M, Rugge M, Chemello L, et al. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. J Hepatol 1996; 24: 301-307.
 
36.
Schmitt-Gräff A, Krüger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138: 1233-1242.
 
37.
Tomanović NR, Boricić I, Brasanac DC, et al. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study. J Gastrointestin Liver Dis 2009; 18: 163-167.
 
38.
Shi J, Hao JH, Ren WH, et al. Pathogenesis of liver fibrosis in patients with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2009; 17: 443-445.
 
39.
Tomanović NR, Boricić I, Brasanac D. Immunohistochemical analysis of alpha-SMA and GFAP expression in liver stellate cells. Vojnosanit Pregl 2006; 63: 553-557.
 
40.
Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 370-379.
 
41.
Okanoue T, Burbige EJ, French SW. The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 1983; 107: 459-463.
 
42.
Page A, Paoli PP, Hill SJ, et al. Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol 2015; 62: 388-397.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top